The authors present a case of a patient with a history of open repair of abdominal aortic aneurysm with a tube graft three years previously presenting with gastrointestinal bleeding as a sign of aortoduodenal fistula. The diagnosis of the fistula was established on the basis of computed tomography angiography, with no source of bleeding found in endoscopy. Endovascular treatment was undertaken due to high operative risk (ASA class IV). A tube stentgraft was implanted covering both anastomoses of the previously implanted prosthesis. In 2-year observation no recurrent gastrointestinal bleeding was noticed.
Aortoduodenic fistula (ADF) constitutes diagnostic and treatment difficulty. Secondary ADF occurs in 0.4-4% of patients after previous aortic surgery (1, 2) . When the bleeding is limited it is usually not depicted in computed tomography. Additionally the time from "herald bleeding" to massive rebleeding is difficult to predict and may be hours to months (3, 4) .
This article presents a case of a patient with gastrointestinal bleeding as a sign of aortoduodenal fistula three years after open repair of abdominal aortic aneurysm which was detected with computed tomography and treated with the use of endovascular method.
CASE REPoRT
A 73-year-old man B.P., (history number 1018/06) was transferred to our hospital with a history of abdominal pain, hematemesis and melaena. These symptoms had never occurred before. Gastroduodenoscopy done in another hospital did not reveal the source of bleeding. Three years previously he had undergone infrarenal abdominal aortic aneurysm (AAA) repair with a tube prosthesis. His medical history also included arterial hypertension, cardiac insufficiency due to extensive myocardial infarction six months previously. on admission the patient was stable, his blood pressure was 90/60 mm Hg and heart rate 85-90/min. He did not complain of abdominal pain and had no fever. C-reactive protein was 15 mg/L and white cell count was 12.3x10 9 /L. Hemoglobin concentration was 7.9 g/dL so two units of red cells were transfused. Computed tomography angiography (CTA) was done after admission with the injection of 140 ml non ionic contrast medium at a flow rate of 4ml/s. Slice thickness was 1.25. It showed fluid and inflammatory infiltration around the proximal anastomosis with the previously implanted aortic graft retracting the third portion of duodenum ( fig.1 ). The diagnosis of aorto-duodenal fistula was established on the basis of CT angiography findings and the absence of any other source of bleeding in consecutive endoscopy.
Taking under consideration high operative risk (ASA class IV) and the possibility of he-Endovascular treatment of upper gastrointestinal bleeding detected with the use of ct angiography morrhage the decision about endovascular treatment was made. The Thoracic Body Extention 32/80 (Cook Inc., Bloomington, IN, USA) was implanted under spinal anesthesia via right arteriotomy. An intravenous bolus of 5000 IU of heparin was given before the delivery system was deployed below the level of renal arteries covering both anastomoses of the previously implanted prosthesis. Control angiogram showed satisfactory stent-graft deployment without endoleaks. The delivery system was removed and the arteriotomy closed. Anticoagulation with subcutaneous 60 mg of enoxaparin was maintained for 7 days, followed with ticlopidine 500 mg two times daily. The patient received clindamycin 600 mg intravenously two times daily for 2 weeks and then orally for one week and was discharged on the 14 th postoperative day. Next clindamycin antibiotic therapy was continued with amoxicillin/clavulanate 625 mg three times daily for 3 consecutive weeks.
Two months after the operation the patient was readmitted to hospital for increasing weakness, chills and fever up to 39ºC. No signs of gastrointestinal bleeding was found. No endoleak, fluid around the stent-graft or peritoneal abscesses were presented in ultrasounds scans. No other abnormalities except leucocytosis up to 18.1x10 9 /L and CRP 9.8 mg/L were found in laboratory tests. Although blood cultures were negative, suspecting Gram negative infection intravenous ciprofloxacin 500 mg two times daily for 10 days was administered and continued orally for the next 10 days. The patient was discharged in good condition with normal temperature and white cell count 8.6x10 9 /L. CTA performed six months after operation showed no perigraft inflammatory infiltration ( fig.2) . Follow-up included color duplex ultrasonography and spiral CT performed at 12 and 18 months following the intervention. In 2-year observation no other signs connected with stent-graft implantation for ADF have been found.
DISCUSSIoN
MDCT not only allowed to depict active bleeding but also to suspect ADF as the bleeding source. If there are some clinical signs of GI bleeding and radiological signs of perigraft infection such as ectopic gas, periaortic fluid or soft tissue thickness > 5mm, loss of the fat pad between the intestine and the aorta, CT has an overall AEF diagnostic specificity of 100% and sensitivity of 50% (5). other hemorrhage sources that may be found using contrast enhancement CT are diverticular disease, angiodysplasia, neoplasms, pseudoaneurysms, aneurysms, colitis and arteriobiliary fistula after liver biopsy (6, 7) .
The prognosis of AEF following open aortic surgery is poor, with high mortality and morbidity rate of 100% if left untreated (8) . Conventional treatment of an ADF consists of extra- anatomic bypass grafting, aortic ligation, and for a secondary ADF also subsequent removal of previously implanted graft. This technique is associated with a 25-90% operative mortality rate, an amputation rate of 5-25% and an aortic stump rupture rate of 10-50% (9). Stent-grafting of an ADF is controversial as the infected graft is not removed and the risk of reinfection remains high. It is essential to administer prolonged broad-spectrum antibiotic therapy to prevent reinfection which is confirmed by other authors (3, 10) . Baril et al. find the endovascular method as an alternative to open surgery in patients with severe comorbidities or in poor general condition caused by active ADF (3). others suggest that endovascular treatment should be followed by the excision of the infected graft together with the stent-graft and extra-anatomic bypass grafting to restore blood flow in lower extremities (3, 10).
During follow-up the patient was admitted only once for septic signs, which subsided after antibiotic treatment. El Sakka et al. described multiple episodes of fever with chills in all five patients with ADF who underwent endovascular treatment. Although blood cultures were negative they administered wide-spectrum antibiotics with regression of symptoms in all cases (9) . Two-year survival of the patient after endovascular treatment of ADF without need for a secondary surgical intervention was surprising. However, drawing the conclusion that this less invasive method of treatment is efficient, is not justified. In every case excision of an infected primary graft together with a stentgraft should be aimed at. Stent-graft implantation may be considered as life-saving operation, giving the possibility of stabilizing a patient's general condition before open repair of ADF. In our patient elective open surgery was rejected
